The Peptide Encyclopedia
Your comprehensive guide to therapeutic peptides. Explore mechanisms, clinical evidence, FDA status, and find clinics that offer them. 117 peptides covered and growing.
Your comprehensive guide to therapeutic peptides. Explore mechanisms, clinical evidence, FDA status, and find clinics that offer them. 117 peptides covered and growing.
Showing 117 peptides
GLP-1 Receptor Agonist
FDA-approved GLP-1 agonist for weight loss and type 2 diabetes.
GIP/GLP-1 Receptor Agonist
Dual GIP/GLP-1 agonist for weight loss and type 2 diabetes.
GLP-1 Receptor Agonist
FDA-approved GLP-1 receptor agonist for weight management and type 2 diabetes.
Triple Incretin Agonist
Retatrutide (LY3437943) is an investigational triple GLP-1/GIP/glucagon receptor agonist from Eli Lilly. In Phase 2 obesity trials it produced up to ~24% mean weight loss at 48 weeks — the highest reported for any obesity drug — but it is not FDA-approved and has no legal commercial source as of 2026.
Amylin Analogue
Cagrilintide is a long-acting amylin analogue in Phase 3 development, studied in combination with semaglutide (CagriSema). The CagriSema combination achieved approximately 22.7% body weight reduction at 68 weeks in the SCALE trial.
GLP-1/Glucagon Dual Agonist
Survodutide (BI 456906) is a dual GLP-1 and glucagon receptor agonist in Phase 3 trials for obesity and MASH (metabolic-associated steatohepatitis), demonstrating approximately 14.9% weight loss at 46 weeks in Phase 2b studies.
GLP-1/Glucagon Dual Agonist
Mazdutide (IBI362) is a weekly GLP-1 and glucagon receptor dual agonist developed by Innovent Biologics, currently in Phase 3 trials in China. Phase 3 GLORY-1 trial data showed 14.5% body weight reduction over 36 weeks.
Amino Acid Derivative
L-Carnitine is a conditionally essential amino acid derivative (β-hydroxy-γ-trimethylaminobutyric acid) that facilitates the transport of long-chain fatty acids across the inner mitochondrial membrane for β-oxidation, serving as a critical cofactor in energy metabolism.
Growth Hormone Releasing Hormone Analog
Stabilized GHRH analog, FDA-approved as Egrifta for excess abdominal fat in adults with HIV lipodystrophy.
Peptide Blend
CagriSema, a compounded combination of the amylin analogue cagrilintide and the GLP-1 agonist semaglutide, studied in Phase 3 REDEFINE trials with approximately 22.7% body weight reduction at 68 weeks.
Growth Hormone Secretagogue
A research peptide blend formulated to investigate growth hormone axis modulation through combined GHRH and ghrelin receptor pathways.
AICAR is a research compound that acts as an AMP analog activating AMP-activated protein kinase (AMPK).
Peptide Blend
A compounded blend combining ipamorelin (ghrelin receptor agonist) with tesamorelin (GHRH analogue) for synergistic GH secretion with tesamorelin's additional visceral fat-reducing properties.
Growth Hormone Fragment
HGH Frag 176-191 is the C-terminal 16 amino acids of growth hormone, sold for fat loss. It has never been tested in people; the human trials used AOD-9604.
AMPK Activator (small molecule)
O-304 (ATX-304) is an oral small-molecule AMPK activator in early trials for type 2 diabetes and obesity. It is not a peptide and not FDA approved.
Targeted proapoptotic compound
Adipotide, also known as FTPP, is a synthetic research peptide designed as a targeted proapoptotic compound.
Growth Hormone Fragment
AOD-9604 is a research peptide consisting of amino acids 177–191 of the human growth hormone sequence.
Peptide Blend
A triple-peptide compounded blend combining AOD-9604 (fat-mobilizing GH fragment) with CJC-1295 and ipamorelin for comprehensive GH-axis optimization with targeted lipolysis.
Triple Monoamine Reuptake Inhibitor
Tesofensine is a synthetic small molecule, not a peptide, that blocks the reuptake of noradrenaline, dopamine and serotonin. It reached phase 2 trials for obesity and is not FDA-approved.
Mitochondrial-Derived Peptide
MOTS-c is a mitochondrial-derived peptide composed of 16 amino acids.
5-amino-1MQ is a small-molecule research compound that functions as a selective nicotinamide N-methyltransferase (NNMT) inhibitor.
Growth Hormone Releasing Hormone
GHRH analog for growth hormone deficiency, formerly FDA-approved as Geref and now compounded by prescription.
Growth Hormone Secretagogue
Combination growth hormone secretagogue therapy.
Growth Hormone
HGH 191AA refers to recombinant human growth hormone (somatropin) with the full 191 amino acid sequence. It is FDA-approved under multiple brand names for growth hormone deficiency, Turner syndrome, and other specific indications.
Thymosin Peptide
Synthetic fragment of thymosin beta-4 used for tissue repair, recovery, and reducing inflammation.
Coenzyme vital for cellular energy, DNA repair, and longevity.
Growth Hormone Releasing Peptide
A selective growth hormone-releasing peptide with minimal side effects.
Growth Hormone Releasing Hormone Analog
A growth hormone-releasing hormone analog that increases GH and IGF-1 levels.
Antioxidant Tripeptide
Glutathione (GSH) is the body's master antioxidant, a tripeptide (γ-Glu-Cys-Gly) synthesized in every cell. IV glutathione bypasses poor oral bioavailability to rapidly replenish intracellular GSH, supporting detoxification, immune function, and skin brightening.
Growth Hormone Releasing Peptide
Potent GHRP that stimulates GH secretion for muscle recovery and anti-aging.
Telomerase Activator
Tetrapeptide that activates telomerase, studied for anti-aging and longevity.
Growth Hormone Releasing Peptide
Growth hormone-releasing peptide that stimulates appetite and GH secretion.
Copper Peptide
Family of copper-binding peptides used for skin rejuvenation, wound healing, and hair growth.
Mitochondria-Targeting Peptide
SS-31 (Elamipretide, MTP-131) is a tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that selectively targets the inner mitochondrial membrane to stabilize cardiolipin, reduce electron leak, and restore mitochondrial cristae architecture in aged and failing mitochondria.
Peptide Blend
Adamax is a branded compounded peptide blend typically combining CJC-1295 DAC, Ipamorelin, and BPC-157, formulated to simultaneously stimulate growth hormone secretion, promote tissue repair, and support recovery — often available as a single reconstitution vial.
Porcine brain peptide mixture
Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids made by controlled digestion of pig brain proteins and given by IV infusion. It is used as a licensed medicine for stroke and dementia in some countries, mainly in Eastern Europe and Asia, but it is not FDA-approved.
Neuropeptide
Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) found in the hypothalamus and peripheral blood that promotes deep (delta-wave) sleep and modulates stress hormone release.
Anticancer Peptide
PNC-27 is a 27-amino acid peptide containing a p53 MDM-2 binding domain fused to a membrane-penetrating sequence, designed to selectively induce apoptosis in cancer cells that aberrantly express HDM-2 (MDM-2) on their plasma membrane.
Russian Bioregulator Peptide
Cardiogen is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Arg) developed at the St. Petersburg Institute of Bioregulation for cardiac tissue restoration, studied for cardiomyocyte protection and heart muscle recovery following ischemia.
Russian Bioregulator Peptide
Testagen is a synthetic tetrapeptide bioregulator (Lys-Glu-Asp-Gly, KEDG) from Khavinson's group in St. Petersburg, marketed for male reproductive health. Published research on KEDG covers DNA and histone binding and a few animal studies; no study has tested it on the testes, testosterone or sperm in people.
Russian Bioregulator Peptide
Cortagen is a synthetic tetrapeptide bioregulator (Ala-Glu-Asp-Pro) developed for vascular and cardiac tissue support, particularly targeting the regulation of blood vessel tone and endothelial function in aging cardiovascular tissue.
Russian Bioregulator Peptide
Livagen is the synthetic tetrapeptide Lys-Glu-Asp-Ala (KEDA), developed by Khavinson's group in St. Petersburg as a liver "bioregulator." Its research is cell, tissue-culture and rat work plus lab studies on white blood cells from elderly donors; no human trial has been published.
Russian Bioregulator Peptide
Crystagen is a synthetic tripeptide bioregulator (Glu-Asp-Pro) from Khavinson's group in St. Petersburg, studied mainly in cell and animal research for effects on immune cells, including B-cell activation in the aging spleen.
Russian Bioregulator Peptide
Cartalax is a synthetic tripeptide bioregulator (Ala-Glu-Asp) developed for cartilage and joint tissue restoration, studied for chondroprotective effects and articular cartilage regeneration in animal models.
Russian Bioregulator Peptide
Chonluten is a synthetic tripeptide bioregulator (Glu-Asp-Gly) developed for bronchial and lung tissue support, studied for airway epithelial protection and pulmonary function restoration in aged and compromised tissue.
Bioregulator
Ovagen is the synthetic tripeptide Glu-Asp-Leu (EDL) from Khavinson's bioregulator program in St. Petersburg. Its published research is rat kidney-injury studies and aging kidney cell cultures; no human trial has been published, and no published study has tested it for the liver or gut.
Research Peptide Blend (BPC-157 + TB-500 + GHK-Cu)
The GLOW peptide blend combines BPC-157, TB-500, and GHK-Cu, three research peptides studied for tissue repair, angiogenesis, and skin and connective-tissue remodeling.
Research Peptide Blend (BPC-157 + TB-500 + KPV + GHK-Cu)
The KLOW peptide blend combines BPC-157, TB-500, KPV, and GHK-Cu, the GLOW blend plus KPV, studied for cellular repair, immune modulation, and extracellular matrix regulation.
Pal-GHK is a research peptide formed by conjugating Gly-His-Lys to palmitic acid to enhance dermal delivery.
Growth Hormone Secretagogue
CJC-1295 (no DAC) and Ipamorelin is a research peptide blend combining two mechanistically distinct secretagogues that act synergistically on the growth hormone axis.
Growth Hormone Secretagogue
MK-677 (ibutamoren) is an oral, non-peptide growth hormone secretagogue developed by Merck. Human trials used 25 mg once daily; it was never FDA approved.
Mitochondrial-Derived Peptide
Humanin is a 24-amino-acid mitochondrial peptide studied in animals for brain, heart and metabolic health. It has never been tested as a treatment in people.
Thymic peptide extract
Thymalin is a calf-thymus peptide extract registered as a prescription immune drug in Russia. Most of its research comes from the group that developed it.
Bioregulator
Vesugen is a synthetic short peptide bioregulator derived from vascular tissue extracts.
Growth Hormone Secretagogue
GHRP-2 is a synthetic hexapeptide that functions as a potent growth hormone secretagogue.
Peptide Blend
The most widely used compounded GH peptide combination, pairing modified GRF 1-29 (CJC-1295 without DAC) with ipamorelin for a clean, pulsatile GH release that mimics natural secretory patterns.
SLU-PP-332 is a small-molecule research compound identified as a selective agonist of peroxisome proliferator-activated receptor delta (PPARδ).
FOXO4-DRI is a synthetic D-retro-inverso research peptide designed to selectively disrupt the FOXO4–p53 interaction.
SNAP-8 is a synthetic octapeptide derived from SNAP-25, designed to modulate vesicle exocytosis-associated protein interactions.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analog of SNAP-25 developed to modulate vesicle docking and catecholamine release.
Lipidated signal peptide (cosmetic ingredient)
Matrixyl is the trade name for palmitoyl pentapeptide-4 (pal-KTTKS), a fatty-acid-linked fragment of type I procollagen used as an anti-wrinkle cosmetic ingredient. It has been studied in people only as a topical cream.
Synthetic Pentapeptide
Vialox (Pentapeptide-3V) is a research peptide designed as a synthetic pentapeptide analog modeled after snake venom proteins.
Pentapeptide-18 (Leuphasyl) is a research peptide derived from the enkephalin sequence, designed to study neuromodulatory mechanisms.
Bioregulator
Pinealon is a synthetic tripeptide bioregulator (Glu-Asp-Arg, EDR) from Khavinson's group in St. Petersburg, studied for neuroprotection in cell and rodent models. Human data is limited to small Russian studies, and no dose has been established.
Bioregulator
Vilon is a synthetic dipeptide bioregulator (Lys-Glu, KE) from Khavinson's group in St. Petersburg, described as thymus-related. Research is mostly cell and rodent work; there is one small human study and no established dose.
Bronchogen is a short tetrapeptide examined in laboratory research for its association with bronchial tissue and lung-related cellular systems.
Bioregulator
Prostamax is a peptide bioregulator derived from prostate tissue extracts that modulates peptide-mediated regulation of cell differentiation and proliferation.
Peptide Blend
A compounded blend of CJC-1295 (GHRH analogue) and GHRP-2 (ghrelin receptor agonist) for synergistic growth hormone stimulation through complementary receptor pathways.
GHK-Cu is a research peptide composed of the tripeptide sequence Gly-His-Lys bound to copper(II) ions, studied for its role in extracellular matrix modulation and cellular signaling.
Relaxin-family peptide analog
B7-33 is a single-chain relaxin-family peptide analog designed to selectively activate the RXFP1 receptor.
AHK-Cu is a research peptide complex studied for its role in extracellular matrix remodeling and fibroblast activation.
AHK (Tripeptide-3) is a research peptide composed of the tripeptide Ala-His-Lys, studied for its effects on dermal fibroblast function and extracellular matrix gene regulation.
Pal-AHK is a research peptide consisting of the tripeptide Ala-His-Lys conjugated with palmitic acid to enhance skin absorption and bioavailability.
Palmitoyl Dipeptide-6 is a research peptide composed of a short dipeptide conjugated to a palmitic acid chain to enhance lipophilicity and dermal penetration.
Rigin is a research peptide designed to modulate cytokine expression and dermal peptide signaling.
Syn-Coll is a research peptide designed to enhance stability and skin permeability for in vitro studies.
Collagen peptide
Tripeptide-29 is a research peptide composed of Gly-Pro-Hyp, studied for its role in extracellular matrix synthesis and fibroblast regulation.
Synthetic Fragment
Research peptide for tissue repair and gut health. FDA advisers backed compounding in July 2026.
Body Protection Compound
15-amino acid peptide related to BPC-157 used for tissue repair and recovery.
IGF-1 Analogue
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is a modified 83-amino acid analogue of IGF-1 with an N-terminal arginine extension and Glu3→Arg3 substitution, conferring a half-life of approximately 20–30 hours versus 12–15 minutes for native IGF-1.
IGF-1 Splice Variant
Mechano Growth Factor (MGF) is an alternatively spliced form of the IGF-1 gene expressed locally in muscle tissue following mechanical stretch or damage, promoting satellite cell activation and muscle repair.
Alpha-MSH Fragment
KPV (Lys-Pro-Val) is a C-terminal tripeptide of alpha-melanocyte stimulating hormone (α-MSH) that retains the anti-inflammatory and gut-healing properties of the parent peptide while being resistant to peptidase degradation. It has demonstrated efficacy in inflammatory bowel disease models.
IGF-1 splice variant
PEG-MGF is a PEGylated splice variant of IGF-1 designed to extend peptide stability and half-life for research applications.
ARA-290 is a synthetic research peptide engineered from the B-helix domain of erythropoietin.
Host Defense Peptide
LL-37 is a cationic α-helical research peptide derived from the C-terminal region of human cathelicidin (hCAP18).
KPV is a synthetic tripeptide fragment derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH).
TB-500 Fragment (17-23) is a research peptide derived from the actin-binding region of Thymosin Beta-4.
The BPC-157 and TB-500 blend combines two well-characterized research peptides studied for their roles in cellular repair, angiogenesis, and tissue remodeling.
Peptide Blend
Tri-Heal is a compounded triple-peptide repair blend combining TB-500 (Thymosin Beta-4 fragment), BPC-157, and KPV for comprehensive anti-inflammatory and tissue regeneration support across musculoskeletal and gut tissues.
Follistatin is a multifunctional glycoprotein studied for its role in growth factor signaling networks.
Follistatin 315 is a research peptide isoform of the follistatin protein that binds and neutralizes activins and myostatin.
Follistatin 344 is a research peptide variant known to bind myostatin and activin-A, modulating TGF-β signaling.
Gonadotropin
Human chorionic gonadotropin (hCG) is a placental glycoprotein hormone that acts like luteinizing hormone. It is FDA-approved for prepubertal cryptorchidism, selected male hypogonadotropic hypogonadism and ovulation induction; clinics also use it off-label alongside testosterone therapy and after anabolic steroid use.
Neuropeptide
Neuropeptide involved in reproductive hormone regulation and sexual health.
Gonadotropin Mixture
Human menopausal gonadotropin (HMG) is a purified gonadotropin preparation derived from the urine of postmenopausal women, containing both FSH and LH activity. It is used primarily for fertility induction and restoration of spermatogenesis.
Neuropeptide
Oxytocin is a nine-amino-acid hormone made in the hypothalamus that drives uterine contractions and milk let-down and also acts in the brain. It is FDA-approved as Pitocin for obstetric use; compounded nasal and subcutaneous forms for anxiety, social or sexual goals are off-label.
Hypothalamic regulatory peptide
Thyrotropin releasing hormone (TRH or Protirelin) is a research peptide that modulates pituitary secretion of thyrotropin (TSH) and prolactin.
Gonadotropin-Releasing Hormone Analog
Triptorelin is a synthetic decapeptide analog of gonadotropin-releasing hormone (GnRH).
Bioregulator
Pancragen is the synthetic tetrapeptide Lys-Glu-Asp-Trp (KEDW, usually amidated) developed by Khavinson's group as a pancreas "bioregulator." It was designed as a copy of a fragment shared by insulin-releasing hormones and has been studied in pancreatic cell cultures, diabetic rats, old monkeys and two small human studies.
Activin Receptor Fusion Protein
ACE-031 (ramatercept) is a myostatin-trapping protein from Acceleron. Its Duchenne trial was stopped in 2011 for nosebleeds and dilated blood vessels.
Follistatin Analog
FLGR-242 is a brand-name follistatin product sold as a modified Follistatin 344 with an albumin-binding tail. No study of it has been published.
Gonadotropin-Releasing Hormone
Gonadorelin is a research peptide corresponding to the natural gonadotropin-releasing hormone (GnRH).
Growth Hormone Secretagogue
GHRH is a 44-amino acid hypothalamic research peptide that stimulates growth hormone release.
Nootropic Peptide
Nootropic peptide studied for cognitive enhancement and neuroprotection.
Nootropic Peptide
P21 (P021) is a small synthetic peptide based on CNTF, studied for memory and Alzheimer's disease in mice and rats. It has never been tested in people.
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment, used in research on neurotrophic and nootropic signaling.
Selank is a synthetic research peptide derived from the natural tuftsin sequence.
PE-22-28 is a research peptide derived from the C-terminal fragment of pituitary adenylyl cyclase-activating polypeptide (PACAP 1–38).
Venom-Derived Peptide
Fraternine is a peptide isolated from the venom of the social wasp Parachartergus fraternus, studied for its potential in neurodegeneration research.
Melanostatin DM is a research peptide analog of the tripeptide Prolyl-Leucyl-Glycinamide (PLG), designed to study melanocyte-stimulating hormone (α-MSH) receptor modulation.
Melanocortin Receptor Agonist
FDA-approved for hypoactive sexual desire disorder.
Melanocortin Peptide
Synthetic melanocortin peptide studied for tanning, sexual dysfunction, and appetite suppression.
α-Melanocyte-Stimulating Hormone Analog
Melanotan I is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) used to study melanocortin receptor activation.
Thymosin Alpha-1 is a synthetic polypeptide consisting of 28 amino acids derived from the thymic hormone thymosin fraction 5.
Thymic peptide
Thymogen is a synthetic dipeptide derived from thymic extracts with regulatory activity in preclinical research.
Neuropeptide
VIP (Vasoactive Intestinal Peptide) is a 28 amino acid neuropeptide that functions as a potent endogenous ligand for VPAC1 and VPAC2 receptors.